Cadila Healthcare SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Cadila Healthcare

Pharmaceuticals

Pharma and Healthcare

The care continues

An integrated healthcare solutions provider, catering to over 45 therapeutic segments.

Respiratory agents, cardiovascular, haematinics, gastrointestinal, analgesics, anti-infective and antibiotics, anti- diabetics and immunological.

Diagnostic, preventive and curative pharmaceutical and diagnostic product seeking healthcare professionals

Marketing of the pharma products to assuage, identify and thwart diseases.

Below are the Strengths in the SWOT Analysis of Cadila Healthcare:

1.USFDA approved plant for clinical trials

2.Sole manufacturer in Indian of Streptokinase and Hyaluronic Acid-based products

3. Caters to over 45 therapeutic areas and has presence in over 90 countries

4. Cadila has acquired Bio-chem which is major player in anti-infective segment in domestic market

5. Recommercialisation of Urokinase through partnership with Microbix

Here are the weaknesses in the Cadila Healthcare SWOT Analysis:

1. Tough competition means the market share is limted

2. Weak international presence compared to a few international brands

Following are the Opportunities in Cadila Healthcare SWOT Analysis:

1. Large penetration strategies in the therapeutic market to increase the market share

2. increasing prevalence of chronic diseases such as diabetes, cancer

3. Penetration of medical insurance

The threats in the SWOT Analysis of Cadila Healthcare are as mentioned:

1. Debt in the foreign currency and weak rupee may cause MTM

2. Economic fluctuations and emergence of global players
3. Govt policies and restrictions in the medical field

Below are the top 5 Cadila Healthcare competitors:

1. Sun Pharma
2. Dr Reddys Labs

3. Cipla

4. Lupin

5. Ranbaxy